Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Amortizatization of Intangibles (2022 - 2024)

Oncology Institute (TOI) has disclosed Amortizatization of Intangibles for 3 consecutive years, with $1000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Amortizatization of Intangibles fell 99.95% year-over-year to $1000.0, compared with a TTM value of $1000.0 through Sep 2025, down 99.96%, and an annual FY2024 reading of $500000.0, down 81.0% over the prior year.
  • Amortizatization of Intangibles was $1000.0 for Q4 2024 at Oncology Institute, down from $48000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.9 million in Q4 2023 and bottomed at -$877000.0 in Q3 2023.
  • Average Amortizatization of Intangibles over 3 years is $415100.0, with a median of $225500.0 recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles tumbled 3124.14% in 2023, then skyrocketed 105.47% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $991000.0 in 2022, then soared by 93.64% to $1.9 million in 2023, then plummeted by 99.95% to $1000.0 in 2024.
  • Business Quant data shows Amortizatization of Intangibles for TOI at $1000.0 in Q4 2024, $48000.0 in Q3 2024, and $127000.0 in Q2 2024.